Estimation of migraine prevalence considering active and inactive states across different age groups.
Classification
Epidemiology
Migraine
Population studies
Prevalence
Remission
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
11 Jul 2023
11 Jul 2023
Historique:
received:
29
03
2023
accepted:
28
06
2023
medline:
12
7
2023
pubmed:
11
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Migraine is a very common headache disorder on the population level, characterized by symptomatic attacks (activity). For many people with migraine, the migraine symptoms intermittently or permanently cease during their lifetime (inactive migraine). The current diagnostic classification of migraine considers two states: active migraine (having migraine symptoms within the last year) and not having active migraine (including both individuals with inactive migraine and those who never had migraine). Defining a state of inactive migraine that has gone into remission may better capture the trajectories of migraine across the lifespan and contribute to a better understanding of its biological processes. We aimed to quantify the prevalence of never, active, and inactive migraine separately, using modern prevalence and incidence estimation methodology to better describe the complexity of migraine trajectories at the population level. Using a multistate modeling approach, data from the Global Burden of Disease (GBD) study, and results from a population-based study, we estimated the transition rates by which individuals moved between migraine disease states and estimated prevalences of never, active and inactive migraine. We used data from the GBD project and a hypothetical cohort of 100,000 people with a starting age of 30 and 30 years of follow-up, both in Germany and globally, stratified by sex. In Germany, the estimated rate of transition from active to inactive migraine (remission rate) increased after the age of 22.5 in women and 27.5 in men. The pattern for men in Germany was similar to the one observed on the global level. The prevalence of inactive migraine among women reaches 25.7% in Germany and 16.5% globally at age 60. For men, the inactive migraine prevalence estimates at the same age were 10.4% in Germany and 7.1% globally. Considering an inactive migraine state explicitly reflects a different epidemiological picture of migraine across the lifecourse. We have demonstrated that many women of older ages may be in an inactive migraine state. Many pressing research questions can only be answered if population-based cohort studies collect information not only on active migraine but also on inactive migraine states.
Sections du résumé
BACKGROUND
BACKGROUND
Migraine is a very common headache disorder on the population level, characterized by symptomatic attacks (activity). For many people with migraine, the migraine symptoms intermittently or permanently cease during their lifetime (inactive migraine). The current diagnostic classification of migraine considers two states: active migraine (having migraine symptoms within the last year) and not having active migraine (including both individuals with inactive migraine and those who never had migraine). Defining a state of inactive migraine that has gone into remission may better capture the trajectories of migraine across the lifespan and contribute to a better understanding of its biological processes. We aimed to quantify the prevalence of never, active, and inactive migraine separately, using modern prevalence and incidence estimation methodology to better describe the complexity of migraine trajectories at the population level.
METHODS
METHODS
Using a multistate modeling approach, data from the Global Burden of Disease (GBD) study, and results from a population-based study, we estimated the transition rates by which individuals moved between migraine disease states and estimated prevalences of never, active and inactive migraine. We used data from the GBD project and a hypothetical cohort of 100,000 people with a starting age of 30 and 30 years of follow-up, both in Germany and globally, stratified by sex.
RESULTS
RESULTS
In Germany, the estimated rate of transition from active to inactive migraine (remission rate) increased after the age of 22.5 in women and 27.5 in men. The pattern for men in Germany was similar to the one observed on the global level. The prevalence of inactive migraine among women reaches 25.7% in Germany and 16.5% globally at age 60. For men, the inactive migraine prevalence estimates at the same age were 10.4% in Germany and 7.1% globally.
CONCLUSIONS
CONCLUSIONS
Considering an inactive migraine state explicitly reflects a different epidemiological picture of migraine across the lifecourse. We have demonstrated that many women of older ages may be in an inactive migraine state. Many pressing research questions can only be answered if population-based cohort studies collect information not only on active migraine but also on inactive migraine states.
Identifiants
pubmed: 37430201
doi: 10.1186/s10194-023-01624-y
pii: 10.1186/s10194-023-01624-y
pmc: PMC10334692
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
83Informations de copyright
© 2023. The Author(s).
Références
Cephalalgia. 2003 Sep;23(7):519-27
pubmed: 12950377
Proc Natl Acad Sci U S A. 1989 Sep;86(18):7113-7
pubmed: 2571150
Neurology. 2014 Jul 15;83(3):278-86
pubmed: 24871874
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Headache Pain. 2020 Mar 17;21(1):27
pubmed: 32183686
BMJ. 2010 Aug 24;341:c3966
pubmed: 20736269
Cephalalgia. 2013 Sep;33(12):1017-25
pubmed: 23588795
J Headache Pain. 2014 Mar 18;15:15
pubmed: 24641507
Neurology. 2007 Jan 30;68(5):343-9
pubmed: 17261680
Pain. 2022 Feb 1;163(2):e293-e309
pubmed: 34001771
Cephalalgia. 2000 Dec;20(10):900-6
pubmed: 11304025
J Headache Pain. 2022 Apr 12;23(1):34
pubmed: 35410119
Nat Rev Dis Primers. 2022 Jan 13;8(1):2
pubmed: 35027572
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
BMJ Open. 2018 Mar 27;8(3):e020498
pubmed: 29593023
Theor Popul Biol. 2014 Mar;92:62-8
pubmed: 24333220
BMJ Open. 2012 Jul 02;2(4):
pubmed: 22761284
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Neurology. 1996 Apr;46(4):907-11
pubmed: 8780061
Cephalalgia. 2011 Apr;31(5):585-96
pubmed: 21123626
Headache. 2015 Jan;55(1):21-34
pubmed: 25600719
Neurology. 2022 Aug 19;:
pubmed: 35985832
PLoS One. 2019 Jan 7;14(1):e0208728
pubmed: 30615622
J Clin Epidemiol. 1991;44(11):1147-57
pubmed: 1941010
BMJ. 2016 May 31;353:i2610
pubmed: 27247281
Lancet Neurol. 2018 Nov;17(11):954-976
pubmed: 30353868
J Headache Pain. 2016;17:9
pubmed: 26879832
Stat Med. 2013 May 30;32(12):2070-8
pubmed: 23034867
J Headache Pain. 2017 Oct 4;18(1):101
pubmed: 28980171